Biopharma Business

Tag "Abeona Therapeutics Inc"

EU Grants Orphan Drug Designation for Epidermolysis Bullosa Treatment

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing gene therapies for life-threatening rare diseases, announced today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products has

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here